Search - tctmd.com

Displaying 1 - 20 of 174

Sort: Relevancy | Date

News Conference News TCT 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Michael O'Riordan

October 27, 2025

Presentation TCT 2025

Long-Term Follow-up of the PARTNER 3 Low-Risk Randomized Trial: Seven-Year Clinical and Echocardiographic Outcomes

Presenter: Michael J. Mack

October 27, 2025

Presentation TCT 2025

PSA/MSA Models to Partner with Hospital Systems: The Devil is in the Details

Presenter: Partha Sardar

October 26, 2025

Presentation TCT 2025

The Cutting Edge of AI in Structural and Valvular Heart Disease: What’s Next?

Presenter: Partho P. Sengupta

October 26, 2025

Presentation TCT 2025

Can AI Perform TEER?: The DeviceGuide AI imaging TEER Guidance Platform

Presenter: Rebecca T. Hahn

October 26, 2025

Presentation TCT 2025

Large Language Processing Models for Automated Echo Reporting and Valvular Disease Screening

Presenter: Chadi Ayoub

October 26, 2025

Presentation TCT 2025

Broadening Patient Access: AI-Enabled Echocardiographic Acquisition By Non Sonographers

Presenter: Akhil Narang

October 26, 2025

Presentation TCT 2025

Management of Aortic Stenosis PLUS... Concomitant and Multivalvular Heart Disease

Presenter: Gilbert H. L. Tang

October 26, 2025

Presentation TCT 2025

Low Flow Low Gradient Severe Aortic Stenosis: How Low Is Too Low To Treat?

Presenter: Matthew John Czarny

October 26, 2025

Presentation TCT 2025

Modern Era and Futuristic Pharmacological Management of Aortic Stenosis: Pre and Post Intervention

Presenter: Chetan Huded

October 26, 2025

Presentation TCT 2025

Earlier Detection of Valvular Heart Disease

Presenter: Pierre Elias

October 26, 2025

Presentation TCT 2025

Addressing Disparities In Aortic Stenosis Management: Have We Made Progress?

Presenter: Wayne Batchelor

October 26, 2025

Presentation TCT 2025

Addressing Undertreatment In Aortic Stenosis: Target AS, Detect AS, and Beyond

Presenter: Sammy Elmariah

October 26, 2025

Presentation TCT 2025

SAVR vs. TAVR Strategy Trials (PARTNER 3 and RHEIA)

Presenter: Marvin H. Eng

October 26, 2025

Presentation TCT 2025

Cath Lab Quality Metrics and AUC: Measuring What Matters

Presenter: James B. Hermiller

October 26, 2025

Presentation TCT 2025

Avoiding Denials and Optimizing Reimbursement in the Cath Lab

Presenter: Larry S. Dean

October 26, 2025

Presentation TCT 2025

Coding the Future: Understanding 2026 CPT Revisions and Their Impact on Practice & Reimbursement

Presenter: Arnold Seto

October 26, 2025

Presentation TCT 2025

PRO – SURGERY: 3 Reasons why Surgery is the Best Option for this Patient

Presenter: Rishi Puri

October 26, 2025

Presentation TCT 2025

PRO – TAVR: 3 Reasons why TAVR is the Best Option for this Patient

Presenter: Michael J. Reardon

October 26, 2025

Presentation TCT 2025

Coding and Documentation Essentials for Coronary and Peripheral Procedures

Presenter: Andrew Michael Goldsweig

October 26, 2025

Advertisement

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Long-Term Follow-up of the PARTNER 3 Low-Risk Randomized Trial: Seven-Year Clinical and Echocardiographic Outcomes

PSA/MSA Models to Partner with Hospital Systems: The Devil is in the Details

The Cutting Edge of AI in Structural and Valvular Heart Disease: What’s Next?

Can AI Perform TEER?: The DeviceGuide AI imaging TEER Guidance Platform

Large Language Processing Models for Automated Echo Reporting and Valvular Disease Screening

Broadening Patient Access: AI-Enabled Echocardiographic Acquisition By Non Sonographers

Management of Aortic Stenosis PLUS... Concomitant and Multivalvular Heart Disease

Low Flow Low Gradient Severe Aortic Stenosis: How Low Is Too Low To Treat?

Modern Era and Futuristic Pharmacological Management of Aortic Stenosis: Pre and Post Intervention

Earlier Detection of Valvular Heart Disease

Addressing Disparities In Aortic Stenosis Management: Have We Made Progress?

Addressing Undertreatment In Aortic Stenosis: Target AS, Detect AS, and Beyond

SAVR vs. TAVR Strategy Trials (PARTNER 3 and RHEIA)

Cath Lab Quality Metrics and AUC: Measuring What Matters

Avoiding Denials and Optimizing Reimbursement in the Cath Lab

Coding the Future: Understanding 2026 CPT Revisions and Their Impact on Practice & Reimbursement

PRO – SURGERY: 3 Reasons why Surgery is the Best Option for this Patient

PRO – TAVR: 3 Reasons why TAVR is the Best Option for this Patient

Coding and Documentation Essentials for Coronary and Peripheral Procedures

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content